Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liming Shao

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
Science Translational Medicine|March 9, 2018
A PET imaging approach for determining EGFR mutation status for improved lung cancer patient managementXilin Sun, Zunyu Xiao, Gongyan Chen, et al.
Bioorganic & Medicinal Chemistry|September 4, 2025
Design, synthesis, and biological activity of novel para-substituted phenylamino and phenyl derivatives of northebaine as selective delta opioid receptor agonistsDenggao Zhang, Jiangwen Gui, Linghui Kong, et al.
ACS Chemical Neuroscience|March 2, 2021
Exploration of the SAR Connection between Morphinan- and Arylacetamide-Based κ Opioid Receptor (κOR) Agonists Using the Strategy of BridgingXiao Liu, Shuang Jiang, Linghui Kong, et al.
European Journal of Medicinal Chemistry|July 6, 2023
Reversal of subtype-selectivity and function by the introduction of a para-benzamidyl substituent to N-cyclopropylmethyl nornepenthoneLinghui Kong, Kuan Ning, Xiao Liu, et al.
Journal of Medicinal Chemistry|April 22, 2024
Discovery of an Ortho-Substituted <i>N</i>-Cyclopropylmethyl-7α-phenyl-6,14-<i>endo</i>ethano-tetrahydronorthebaine Derivative as a Selective and Potent Kappa Opioid Receptor Agonist with Subsided Sedative EffectZixiang Li, Rufeng Ye, Qian He, et al.
Bioorganic & Medicinal Chemistry|November 25, 2010
Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitorsLiming Shao, Fengjiang Wang, Scott C Malcolm, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
From RORγt Agonist to Two Types of RORγt Inverse AgonistsYonghui Wang, Wei Cai, Ting Tang, et al.
Journal of Medicinal Chemistry|July 28, 2025
Structure-Activity Relationship of <i>N</i>-Cyclopropylmethyl-7α-[<i>para</i>-(arylcarboxamido)phenyl]-6,14-<i>endo</i>ethano-tetrahydronorthebaines as Potent and Selective Kappa Opioid Receptor AgonistsLinghui Kong, Songyu Yao, Denggao Zhang, et al.
European Journal of Medicinal Chemistry|March 11, 2025
Structure-activity relationship analysis of meta-substituted N-cyclopropylmethyl-nornepenthones with mixed KOR/MOR activitiesSiyuan Tang, Shuyang Hu, Lijing Feng, et al.
Journal of Medicinal Chemistry|November 19, 2019
Discovery of a Highly Selective and Potent κ Opioid Receptor Agonist from <i>N</i>-Cyclopropylmethyl-7α-phenyl-6,14-endoethanotetrahydronorthebaines with Reduced Central Nervous System (CNS) Side Effects Navigated by the Message-Address ConceptLi Xiao, Yujun Wang, Mumei Zhang, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
Science Translational Medicine|March 9, 2018
A PET imaging approach for determining EGFR mutation status for improved lung cancer patient managementXilin Sun, Zunyu Xiao, Gongyan Chen, et al.
Bioorganic & Medicinal Chemistry|September 4, 2025
Design, synthesis, and biological activity of novel para-substituted phenylamino and phenyl derivatives of northebaine as selective delta opioid receptor agonistsDenggao Zhang, Jiangwen Gui, Linghui Kong, et al.
ACS Chemical Neuroscience|March 2, 2021
Exploration of the SAR Connection between Morphinan- and Arylacetamide-Based κ Opioid Receptor (κOR) Agonists Using the Strategy of BridgingXiao Liu, Shuang Jiang, Linghui Kong, et al.
European Journal of Medicinal Chemistry|July 6, 2023
Reversal of subtype-selectivity and function by the introduction of a para-benzamidyl substituent to N-cyclopropylmethyl nornepenthoneLinghui Kong, Kuan Ning, Xiao Liu, et al.
Journal of Medicinal Chemistry|April 22, 2024
Discovery of an Ortho-Substituted <i>N</i>-Cyclopropylmethyl-7α-phenyl-6,14-<i>endo</i>ethano-tetrahydronorthebaine Derivative as a Selective and Potent Kappa Opioid Receptor Agonist with Subsided Sedative EffectZixiang Li, Rufeng Ye, Qian He, et al.
Bioorganic & Medicinal Chemistry|November 25, 2010
Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitorsLiming Shao, Fengjiang Wang, Scott C Malcolm, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
From RORγt Agonist to Two Types of RORγt Inverse AgonistsYonghui Wang, Wei Cai, Ting Tang, et al.
Journal of Medicinal Chemistry|July 28, 2025
Structure-Activity Relationship of <i>N</i>-Cyclopropylmethyl-7α-[<i>para</i>-(arylcarboxamido)phenyl]-6,14-<i>endo</i>ethano-tetrahydronorthebaines as Potent and Selective Kappa Opioid Receptor AgonistsLinghui Kong, Songyu Yao, Denggao Zhang, et al.
European Journal of Medicinal Chemistry|March 11, 2025
Structure-activity relationship analysis of meta-substituted N-cyclopropylmethyl-nornepenthones with mixed KOR/MOR activitiesSiyuan Tang, Shuyang Hu, Lijing Feng, et al.
Journal of Medicinal Chemistry|November 19, 2019
Discovery of a Highly Selective and Potent κ Opioid Receptor Agonist from <i>N</i>-Cyclopropylmethyl-7α-phenyl-6,14-endoethanotetrahydronorthebaines with Reduced Central Nervous System (CNS) Side Effects Navigated by the Message-Address ConceptLi Xiao, Yujun Wang, Mumei Zhang, et al.
Pageof 18